Home
>
National Drug Code (NDC)
>
Revonto
Revonto - 27505-003-67 - (dantrolene sodium)
Drug Information of Revonto
| Product NDC: | 27505-003 |
| Proprietary Name: | Revonto |
| Non Proprietary Name: | dantrolene sodium |
| Active Ingredient(s): | 20 mg/60mL & nbsp; dantrolene sodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Revonto
| Product NDC: | 27505-003 |
| Labeler Name: | US WorldMeds, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078378 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120604 |
Package Information of Revonto
| Package NDC: | 27505-003-67 |
| Package Description: | 6 VIAL, GLASS in 1 CARTON (27505-003-67) > 60 mL in 1 VIAL, GLASS |
NDC Information of Revonto
| NDC Code | 27505-003-67 |
| Proprietary Name | Revonto |
| Package Description | 6 VIAL, GLASS in 1 CARTON (27505-003-67) > 60 mL in 1 VIAL, GLASS |
| Product NDC | 27505-003 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | dantrolene sodium |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120604 |
| Marketing Category Name | ANDA |
| Labeler Name | US WorldMeds, LLC |
| Substance Name | DANTROLENE SODIUM |
| Strength Number | 20 |
| Strength Unit | mg/60mL |
| Pharmaceutical Classes | Decreased Striated Muscle Contraction [PE],Decreased Striated Muscle Tone [PE],Skeletal Muscle Relaxant [EPC] |
